Aytu BioPharma, Inc. (NASDAQ:AYTU) Q1 2025 Earnings Call Transcript
Q1 2025 Earnings Call Transcript November 13, 2024 Operator: Greetings. Welcome to the Aytu BioPharma Fiscal 2025 Q1 Earnings ...
Does fluoride cause cancer, IQ loss and more? Fact-checking Robert F. Kennedy Jr.’s claim
Longtime research has shown that drinking fluoridated water at the recommended levels is safe and beneficial for oral health, ...
Aytu BioPharma, Inc.: Aytu BioPharma Reports Fiscal 2025 First Quarter Operational and ...
Net income of $1.5 millionAdjusted EBITDA1 of $1.9 millionADHD Portfolio net revenue up 1% to $15.3 millionPediatric Portfolio net revenue up 54% sequentially$20.1 million cash balance at September 30 ...